Sunday, 20 September 2026European Markets

AXA NV23 Stock 11.69% Up On Thursday

Loading stream...

(vianews) - the market ended the session with axa nv23 (csnv.pa) jumping 11.69% to €28.66 on thursday, after five sequential sessions in a row of losses. cac 40 rose 0.11% to €7,139.25, after three sequential sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

axa nv23's last close was €25.66, 2.6% higher than its 52-week high of €25.01.

about axa nv23

axa sa, through its subsidiaries, provides insurance, asset management, and banking services worldwide. the company operates through france, europe, asia, axa xl, international, and transversal & central holdings segments. it offers life and savings insurance products, such as savings and retirement, other health, and personal protection products. the company also provides property and casualty insurance products, including car, home, and personal or professional liability to individual and business clients; international insurance for large corporate clients in europe; and marine and aviation, as well as property and casualty reinsurance products. in addition, it offers asset management services in the areas of various asset classes, including equities, bonds, hedge funds, private equity, and real estate for the group's insurance companies and their clients, and retail and institutional clients. the company was founded in 1852 and is based in paris, france.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.69%.

revenue growth

year-on-year quarterly revenue growth declined by 23.7%, now sitting on 107.73b for the twelve trailing months.

more news about axa nv23 (csnv.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com